Doctor of Osteopathy Program year 2023 Reported 2019–2023 Source: CMS Open Payments, 2026 publication

Andrew Lister

Psychiatry North Port, FL Doctor of Osteopathy

NPI 1992167191 CMS profile 5702557

2268 Darley Oak Way, North Port, FL 34289

Open in the dashboard

General payments

$745

38 records reported · program years 2019–2023

Research payments

$0

Paid to them · None reported · program years 2019–2023

Ownership & investment interest

$0

None reported

Through program year 2023, Andrew Lister of North Port, FL is reported in the CMS Open Payments database as having received $745 across 38 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2023 General $95 1
2022 General $269 15
2021 General $161 9
2020 General $36 2
2019 General $184 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Andrew Lister
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Andrew Lister were reported at $0. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Andrew Lister Psychiatry median Middle half National median
2019 $184 $184 $59–$605 $163
2020 $36 $119 $36–$372 $114
2021 $161 $143 $43–$576 $132
2022 $269 $153 $50–$590 $149
2023 $95 $170 $56–$651 $160
2024 $0 $179 $57–$673 $164
2025 $0 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2023
  1. AbbVie, Inc. $127 3 payments
  2. Alkermes, Inc. $75 4 payments
  3. Teva Pharmaceuticals USA, Inc. $66 3 payments
  4. Corium, Inc. $63 3 payments
  5. Almatica Pharma LLC $62 4 payments
  6. Otsuka America Pharmaceutical, Inc. $49 3 payments
  7. Avanir Pharmaceuticals, Inc. $46 3 payments
  8. Tris Pharma Inc $46 3 payments
  9. Sunovion Pharmaceuticals Inc. $39 2 payments
  10. Neuronetics, Inc. $39 2 payments
  11. Other $134 8 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2023
  1. Food and Beverage $745 38 payments
Products named General payments · program years 2019–2023
  1. VRAYLAR $127 3 payments
  2. ARISTADA Cns $75 4 payments
  3. ARISTADA Cns $75 4 payments
  4. ARISTADA Cns $75 4 payments
  5. ARISTADA Cns $75 4 payments
  6. ARISTADA INITIO $75 4 payments
  7. AUSTEDO $66 3 payments
  8. Azstarys $63 3 payments
  9. LOREEV XR $62 4 payments
  10. SERTRALINE HCL $48 3 payments
  11. Other $400 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 36 drugs

Part D claims

1,809

Median for Psychiatry: 574

Drug cost

$189,768

Median for Psychiatry: $27,624

Branded share of claims

16.9%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ingrezza Valbenazine Tosylate Brand 14 $119,294
Rexulti Brexpiprazole Brand 12 $20,074
Aripiprazole Generic 51 $8,686
Belsomra Suvorexant Brand 19 $6,964
Vyvanse Lisdexamfetamine Dimesylate Brand 17 $6,532
Vilazodone Hcl Generic 18 $3,275
Quetiapine Fumarate Generic 119 $2,351
Paroxetine Hcl Generic 38 $2,068
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 39 $1,781
Alprazolam Generic 252 $1,739

The 10 drugs with the highest cost, of 36 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$33,312

Medicare's payments for the services billed

Medicare patients

56

Average age 66

Services billed

451

39 women, 17 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Depression 75%
Arthritis 48%
Ischemic heart disease 25%
Diabetes 23%
Chronic kidney disease 23%
COPD 20%
Cancer 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

38 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2023

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record